Lack of KISS1R expression is associated with rapid progression of conventional renal cell carcinomas

Journal of Pathology

Volumn 223, Issue 1, 2011, Pages 46-53

  Chen, Ying ^a   Yusenko, Maria V ^a   Kovacs, Gyula ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

gene expression; KISS1R; renal cell carcinoma; tumour progression

Indexed keywords

G PROTEIN COUPLED RECEPTOR 54; GELATINASE A; GELATINASE B; KISSPEPTIN; METASTIN;

ARTICLE; CANCER GROWTH; CANCER INVASION; CELL INVASION; CELL MOTILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FOLLOW UP; GENE ACTIVATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KIDNEY CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CARCINOMA, RENAL CELL; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 78650014689     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2764     Document Type: Article

References (32)

1. Pantuck AJ, Zisman A, Belldegrun AS,. The changing natural history of renal cell carcinoma. J Urol 2001; 166: 1611-1623.
2. Zisman A, Pantuck AJ, Chao D, et al., Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm better correlates with clinical outcome. J Urol 2001; 166: 54-58.
3. Lee JH, Miele ME, Hicks DJ, et al., KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 1996; 88: 1731-1737.
4. Ohtaki T, Shintani Y, Honda S, et al., Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 2001; 411: 613-617.
5. Muir AI, Chamberlain L, Elshourbagy NA, et al., AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem 2001; 276: 28969-28975.
6. Kotani M, Detheux M, Vandenbogaerde A, et al., The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 2001; 276: 34631-34636.
7. Kovacs G, Akhtar M, Beckwith BJ, et al., The Heidelberg classification of renal cell tumours. J Pathol 1997; 183: 131-133.
8. Kovacs G, Frisch S,. Clonal chromosome abnormalities in tumour cells from patients with sporadic renal cell carcinomas. Cancer Res 1989; 49: 651-659.
9. Yusenko MV, Zubakov D, Kovacs G,. Gene expression profiling of chromophobe renal cell carcinomas and renal oncocytomas by Affymetrix GeneChip using pooled and individual tumours. Int J Bio Sci 2009; 5: 517-527.
10. Saeed AI, Sharov V, White J, et al., TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003; 34: 374-378.
11. Subramanian A, Tamayo P, Mootha VK, et al., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550.
12. Shoji S, Tang XY, Umemura S, et al., Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor. Eur Urol 2009; 55: 441-449.
13. Harms JF, Welch DR, Miele ME,. KISS1 metastasis suppression and emergent pathways. Clin Exp Metast 2003; 20: 11-18.
14. Bilban M, Ghaffari-Tabrizi N, Hintermann E, et al., Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts. J Cell Sci 2004; 117: 1319-1328.
15. Steeg PS,. Metastasis suppressor alter the signal transduction of cancer cells. Nat Rev Cancer 2003; 3: 55-63.
16. Shirasaki F, Takata M, Hatta N, et al., Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. Cancer Res 2001; 61: 7422-7425.
17. Nash KT, Welch DR,. The KISS1 metastasis suppressor: mechanistic insights and clinical utility. Front Biosci 2006; 11: 647-659.
18. Hori A, Honda S, Asada M, et al., Metastin suppresses the motility and growth of CHO cells transfected with its receptor. Biochem Biophys Res Commun 2001; 286: 958-963.
19. Yan C, Wang H, Boyd DD,. KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-κB binding to the promoter as a consequence of IκBα-induced block of p65/p50 nuclear translocation. J Biol Chem 2001; 276: 1164-1172.
20. Park MJ, Park IC, Hur JH, et al., Protein kinase C activation by phorbol ester increases in vitro invasion through regulation of matrix metalloproteinases/tissue inhibitors of metalloproteinases system in D54 human glioblastoma cells. Neurosci Lett 2000; 290: 201-214.
21. Jiang Y, Berk M, Singh LS, et al., KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase Cα. Clin Exp Metastasis 2005; 22: 369-376.
22. Van Kempen LC, Coussens LM,. MMP9 potentiates pulmonary metastasis formation. Cancer Cell 2002; 2: 251-252.
23. Cowden Dahl KD, Symowicz J, Ning Y, et al., Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Res 2008; 68: 4606-4613.
24. Mitra S, Goto M, Lee JS, et al., Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma. Cancer Res 2008; 68: 3959-3969.
25. Zhong WD, Han ZD, He HC, et al., CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer. Oncology 2008; 75: 230-236.
26. Bjorklund M, Koivunen E,. Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 2005; 1755: 37-69.
27. Takino T, Koshikawa N, Miyamori H, et al., Cleavage of metastasis suppressor gene product KISS-1 protein/metastin by matrix metalloproteinases. Oncogene 2003; 22: 4617-4626.
28. Stetler-Stevenson WG, Aznavoorian S, Liotta LA,. Tumour cell interactions with extracellular matrix during invasion and metastasis. Ann Rev Cell Biol 1993; 4: 541-573.
29. Nomura H, Sato H, Seiki M, et al., Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 1995; 55: 3263-3266.
30. Ueno H, Nakamura H, Inoue M, et al., Expression and tissue localisation of membrane-types 1, 2 and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 1997; 57: 2055-2060.
31. Engers R, Springer E, Michiels F, et al., Rac affects invasion of human renal cell carcinomas by up-regulating tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2 expression. J Biol Chem 2001; 276: 41889-41897.
32. Nash KT, Phadke PA, Navenot JM, et al., Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumour dormancy. J Natl Cancer Inst 2007; 99: 309-321.